SCHEMBL9704521

SCHEMBL9704521

COc1cc(OS(C)(=O)=O)ccc1-c1nc2cc3c(=O)[nH]c(C)c(C)c3cc2[nH]1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 2/20 0.42
CCND1 P24385 2/20 0.42
AMY1A P0DUB6 5/20 0.40
PDE2A O00408 1/20 0.39
KDM4E B2RXH2 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
CCND3 P30281 1/20 0.37
PDE3B Q13370 2/20 0.36
PDE3A Q14432 2/20 0.36
PDE5A O76074 1/20 0.36
HPGD P15428 1/20 0.36
GUSB P08236 1/20 0.36
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9703323 0.86 CDK4 (0.47) CDK4CCND1AMY1ACCNA2CDK2
SCHEMBL10745609 0.83 AMY1A (0.58) AMY1APDE2AKDM4ECYP1A2CYP3A4
SCHEMBL9703617 0.82 AMY1A (0.42) AMY1APDE3BPDE3APDE5ATP53
SCHEMBL10764848 0.81 PDE2A (0.47) CDK4CCND1AMY1APDE2AKDM4E
SCHEMBL9704539 0.80 AMY1A (0.40) CDK4CCND1AMY1ACCNA2CDK2
SCHEMBL10741648 0.80 PDE2A (0.44) CDK4CCND1AMY1APDE2AKDM4E
SCHEMBL10744183 0.80 PDE2A (0.51) CDK4CCND1AMY1APDE2AKDM4E
SCHEMBL10970632 0.79 PDE2A (0.45) CDK4CCND1AMY1APDE2AKDM4E
SCHEMBL9678840 0.78 KDM4E (0.43) CDK4CCND1AMY1APDE2AKDM4E
SCHEMBL10743168 0.78 AMY1A (0.54) CDK4CCND1AMY1APDE2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5116843-A Anticoagulants, hypotensive agents and cardiovascular disorder BOEHRINGER MANNHEIM GMBH (DE) 1992-05-26 US disclosed
EP-0275888-A2 Tricyclic benzimidazoles, process for their preparation and use as medicaments Roche Diagnostics GmbH (DE) 1988-07-27 EP disclosed